Wolverine Blend (BPC-157 + TB-500) 20mg — Vial Spec, Reconstitution Math & COA

Overview of the 20mg Wolverine Blend Vial in Preclinical Research

A 20mg vial of the wolverine blend (bpc-157 + tb-500) 20mg contains a combined mass of two distinct synthetic research peptides: 10mg of Body Protection Compound-157 (BPC-157) and 10mg of Thymosin Beta-4 fragment (TB-500). This dual-peptide co-lyophilized formulation provides research laboratories with a unified substrate to evaluate compound interactions, vascular signaling, extracellular matrix (ECM) remodeling, and cellular migration pathways in controlled experimental setups.

Principal investigators and laboratory managers typically order the 20mg total mass configuration for high-throughput assays, longitudinal multi-plate cellular studies, or multi-animal rodent research protocols where consistency across experimental blocks is essential. Sourcing both target compounds in a single, high-yield vial minimizes lot-to-lot variance across control and experimental arms while optimizing volumetric pipetting steps.

PX1 Research Catalog Availability & Formulation Specifications

To maintain optimal structural stability during lyophilization and eliminate chemical cross-reactivity during extended storage, PX1 Research manufactures precise dual-peptide formulations under rigorous ISO 17025 and cGMP-compliant laboratory controls. Principal investigators evaluating custom high-density protocols should note that while PX1 provides specialized custom manufacturing capabilities for large-volume research orders, our standard catalog stock offers the widely utilized Wolverine Blend 10mg (5mg BPC-157 / 5mg TB-500) matrix.

For studies requiring individual single-agent control assays or customized ratio testing, researchers can also review our complete research peptide catalog to source standalone high-purity single-vial variants. Every lot produced across all vial sizes undergoes identity, purity, and mass verification prior to release, ensuring reliable bioactivity across all assay models.

Molecular Profiles: BPC-157 and TB-500 Signaling Mechanisms

BPC-157 is a 15-amino-acid synthetic peptide derived from human gastric juice protein fragments. In vitro and preclinical rodent models indicate that BPC-157 interacts with the focal adhesion kinase (FAK) and paxillin pathway, modulating vascular endothelial growth factor (VEGF) expression and accelerating early-stage angiogenesis. Preclinical studies suggest that its cytoprotective actions are mediated through nitric oxide (NO) synthase modulation and nitric oxide production regulation under oxidative stress conditions.

TB-500 is a synthetic peptide fragment corresponding to the active region of Thymosin Beta-4 (specifically amino acids 17–23, Ac-LKKTETQ). In cellular models, TB-500 functions primarily as an actin-sequestering protein derivative, promoting G-actin binding, cell motility, lamellipodia formation, and rapid cell migration across damaged tissue matrices. When combined in laboratory models, these peptides allow researchers to investigate dual-pathway effects combining neo-vascularization signaling with structural cell migration.

For detailed biochemical specifications on individual peptides, explore our detailed BPC-157 research profile alongside our TB-500 analytical overview to cross-reference target receptor affinities and binding assays.

Reconstitution Mathematics for a 20mg Total Mass Payload

Accurate concentration calculations are vital when reconstituting a high-mass 20mg co-lyophilized matrix. Because the vial contains 10mg of BPC-157 and 10mg of TB-500 (20mg total active peptide mass), working solution concentrations must account for total solute mass relative to diluent volume. Reconstitution should always be performed using laboratory-grade Bacteriostatic Water (0.9% benzyl alcohol) or sterile 0.1% acetic acid diluent depending on specific assay requirements.

When introducing 1.0 mL of sterile diluent into a 20mg total vial, the resultant total peptide concentration is 20.0 mg/mL (10.0 mg/mL BPC-157 + 10.0 mg/mL TB-500). In this state, each 0.01 mL (10 µL) micro-aliquot delivered via precision micro-pipette yields 200 µG of total combined compound (100 µG BPC-157 and 100 µG TB-500).

Introducing 2.0 mL of diluent yields a total concentration of 10.0 mg/mL (5.0 mg/mL BPC-157 + 5.0 mg/mL TB-500). Under this volumetric baseline, a 10 µL dispense delivers 100 µG total peptide mass (50 µG of each active constituent). Adding 3.0 mL of diluent reduces the total concentration to approximately 6.67 mg/mL (3.33 mg/mL per component), providing fine-tuned concentration control for low-dose microplate assays. Researchers can model custom diluent-to-mass ratios utilizing our digital reconstitution calculator.

Aliquot Planning, Liquid Stability, and Storage Parameters

Lyophilized wolverine blend (bpc-157 + tb-500) 20mg vials maintain optimal structural integrity when stored in dark, desiccated environments at -20°C to -80°C. Under these conditions, the cake remains stable against hydrolytic degradation for up to 24 months. Upon reconstitution with preserved diluent (such as bacteriostatic water), the liquid solution should be maintained at 2°C to 8°C and utilized within 28 days.

To prevent degradation caused by repeated freeze-thaw cycles, laboratories utilizing reconstituted solutions over extended experimental windows should immediately aliquot the stock into sterile, low-binding microcentrifuge tubes. Freezing reconstituted aliquots at -80°C preserves peptide secondary structure, though researchers must ensure aliquots are thawed only once prior to in vitro application or binding analysis.

Analytical Quality Verification: COA, HPLC, MS, and Endotoxin Testing

To ensure reproducible experimental conditions, PX1 Research subjects every production lot to comprehensive analytical verification. Each batch is evaluated via High-Performance Liquid Chromatography (HPLC) to confirm peptide purity levels exceeding 99.0%, alongside Mass Spectrometry (MS) to verify precise molecular weight identities for both BPC-157 (1419.5 Da) and TB-500 (889.0 Da).

Furthermore, because bacterial endotoxins can confound cell culture viability and induce artifactual inflammatory responses, every lot undergoes Chromogenic LAL testing to enforce strict endotoxin limits (<0.05 EU/mg). Laboratory teams can review and download lot-matched analytical documentation directly through our centralized certificate of analysis repository.

Vial Selection Criteria: Evaluating 20mg vs. Lower Mass Formulations

Choosing between a high-capacity 20mg vial and lower-mass alternatives (such as 5mg or 10mg total vials) depends entirely on experimental design, assay volume requirements, and planned reconstitution lifespans. High-throughput screening protocols and multi-subject preclinical rodent trials benefit from 20mg vials due to reduced vial-handling overhead and unified lot consistency across extensive sampling runs.

Conversely, small-scale pilot studies, transient cell culture assays, or sporadic receptor-binding experiments are often better served by lower mass configurations. Utilizing smaller total masses prevents waste and avoids solution degradation when total liquid volume cannot be consumed within the recommended 28-day stability window.

Comparative Analysis: Dual Blends vs. Alternative Regenerative Peptides

In cytoprotective and tissue regeneration research, investigators frequently compare the dual-action mechanism of the Wolverine Blend against individual peptide agents or alternative signaling complexes. While the Wolverine Blend simultaneously targets actin cytoskeletal re-organization and VEGF-mediated endothelial sprouting, peptides like GHK-Cu research compounds operate predominantly through copper-dependent gene transcription, collagen synthesis modulation, and antioxidant enzyme upregulation.

Similarly, growth hormone secretagogues such as Ipamorelin or CJC-1295 no DAC influence tissue repair indirectly via endocrine axis stimulation and systemic IGF-1 signaling cascades. Understanding these distinct pathways allows researchers to select appropriate single or multi-target peptides for specific in vitro assays or comparative disease models, as discussed across our cellular migration markers technical guides.

Procurement Practices and Institutional Account Setup

PX1 Research operates as a primary USA-based supplier dedicated exclusively to serving academic institutions, biotechnology companies, and private research facilities. All orders originate from our temperature-controlled distribution centers in California and Arizona, with same-day shipping applied to all orders placed Monday through Friday prior to cutoff times.

Institutions requiring high-volume recurring orders, custom vial fill specifications, or formal procurement invoicing can establish verified enterprise accounts via our bulk research accounts portal. Our technical support team provides comprehensive lot verification data, analytical documentation, and custom synthesis quotes for qualified institutional facilities.